MF59-adjuvanted influenza vaccine

BIOLOGICAL2 trials

Sponsors

Oriol Manuel, Korea University Guro Hospital

Conditions

Immune ResponseInfluenzaInfluenza VaccinesMicrobiomeOrgan Transplantation

Phase 2

Reducing the Burden of Influenza After Solid-Organ Transplantation

CompletedNCT03699839

Oriol ManuelInfluenza, Organ Transplantation

Start: 2018-10-26End: 2020-08-15Updated: 2020-12-17

Phase 4

Comparative Immunologic Mechanisms and Microbiome Interactions Following Different Influenza Vaccine Formulations in Older Adults

CompletedNCT07805837

Korea University Guro HospitalImmune Response, Influenza, Influenza Vaccines +1

Start: 2025-10-25End: 2026-08-31Updated: 2026-09-04

Related Papers

Immunogenicity of High-Dose Versus MF59-Adjuvanted Versus Standard Influenza Vaccine in Solid Organ Transplant Recipients: The Swiss/Spanish Trial in Solid Organ Transplantation on Prevention of Influenza (STOP-FLU Trial)

Clinical Infectious Diseases2023-08-1616 citations